Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Adavosertib by AstraZeneca for Vaginal Cancer: Likelihood of Approval
Adavosertib is under clinical development by AstraZeneca and currently in Phase I for Vaginal Cancer. According to GlobalData, Phase I...
Adavosertib by AstraZeneca for Cervical Cancer: Likelihood of Approval
Adavosertib is under clinical development by AstraZeneca and currently in Phase I for Cervical Cancer. According to GlobalData, Phase I...
Adavosertib by AstraZeneca for Small-Cell Lung Cancer: Likelihood of Approval
Adavosertib is under clinical development by AstraZeneca and currently in Phase II for Small-Cell Lung Cancer. According to GlobalData, Phase...
Adavosertib by AstraZeneca for Triple-Negative Breast Cancer (TNBC): Likelihood of Approval
Adavosertib is under clinical development by AstraZeneca and currently in Phase II for Triple-Negative Breast Cancer (TNBC). According to GlobalData,...
Adavosertib by AstraZeneca for Endometrial Cancer: Likelihood of Approval
Adavosertib is under clinical development by AstraZeneca and currently in Phase II for Endometrial Cancer. According to GlobalData, Phase II...